Technical Analysis for VBLT - Vascular Biogenics Ltd.

Grade Last Price % Change Price Change
grade C 1.71 3.01% 0.05
VBLT closed up 3.01 percent on Monday, March 18, 2019, on approximately normal volume.

Earnings due: Mar 28

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical VBLT trend table...

Date Alert Name Type % Chg
Mar 15 Boomer Buy Setup Bullish Swing Setup 3.01%
Mar 15 Narrow Range Bar Range Contraction 3.01%
Mar 15 Overbought Stochastic Strength 3.01%
Mar 14 MACD Bearish Signal Line Cross Bearish 2.70%
Mar 14 Spinning Top Other 2.70%
Mar 14 Inside Day Range Contraction 2.70%
Mar 14 Overbought Stochastic Strength 2.70%
Mar 13 Earnings Movers Other 1.79%
Mar 13 Wide Bands Range Expansion 1.79%
Mar 13 Overbought Stochastic Strength 1.79%

Older signals for VBLT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates include VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, as well as VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Or Yehuda, Israel.
Medicine Health Biotechnology Biopharmaceutical Cancer Medical Specialties Pharmaceutical Industry Autoimmune Diseases Clinical Trial Ovarian Cancer Psoriasis Ulcerative Colitis Treatment Of Ovarian Cancer Brain Cancer Recurrent Glioblastoma Thyroid Cancer
Is VBLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.1
52 Week Low 0.6
Average Volume 151,093
200-Day Moving Average 1.5956
50-Day Moving Average 1.3767
20-Day Moving Average 1.5893
10-Day Moving Average 1.6515
Average True Range 0.0612
ADX 56.1
+DI 33.1269
-DI 4.4052
Chandelier Exit (Long, 3 ATRs ) 1.5464
Chandelier Exit (Short, 3 ATRs ) 1.5036
Upper Bollinger Band 1.7779
Lower Bollinger Band 1.4007
Percent B (%b) 0.82
BandWidth 23.733719
MACD Line 0.0921
MACD Signal Line 0.0951
MACD Histogram -0.003
Fundamentals Value
Market Cap 46.18 Million
Num Shares 27 Million
EPS -0.67
Price-to-Earnings (P/E) Ratio -2.55
Price-to-Sales 0.00
Price-to-Book 4.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.80
Resistance 3 (R3) 1.80 1.76 1.79
Resistance 2 (R2) 1.76 1.74 1.77 1.78
Resistance 1 (R1) 1.74 1.73 1.75 1.74 1.77
Pivot Point 1.70 1.70 1.71 1.71 1.70
Support 1 (S1) 1.68 1.68 1.69 1.68 1.65
Support 2 (S2) 1.64 1.67 1.65 1.64
Support 3 (S3) 1.62 1.64 1.64
Support 4 (S4) 1.62